225 related articles for article (PubMed ID: 29620964)
21. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
[No Abstract] [Full Text] [Related]
22. Prognostic value of the 8
Ito Y; Miyauchi A; Hirokawa M; Yamamoto M; Oda H; Masuoka H; Sasai H; Fukushima M; Higashiyama T; Kihara M; Miya A
Endocr J; 2018 Jul; 65(7):707-716. PubMed ID: 29681581
[TBL] [Abstract][Full Text] [Related]
23. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M; Kim YN; Kim WG; Park S; Kwon H; Jeon MJ; Ahn HS; Jung SH; Kim SW; Kim WB; Chung JH; Shong YK; Kim TH; Kim TY
Clin Endocrinol (Oxf); 2017 Mar; 86(3):438-443. PubMed ID: 27731521
[TBL] [Abstract][Full Text] [Related]
24. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
25. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
26. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Perrier ND; Brierley JD; Tuttle RM
CA Cancer J Clin; 2018 Jan; 68(1):55-63. PubMed ID: 29092098
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer.
Zhang H; Zhao YC; Wu Q; Wang L; Sun S
Clin Endocrinol (Oxf); 2021 Sep; 95(3):498-507. PubMed ID: 33864292
[TBL] [Abstract][Full Text] [Related]
28. TNM classification of thyroid carcinoma.
Shaha AR
World J Surg; 2007 May; 31(5):879-87. PubMed ID: 17308849
[TBL] [Abstract][Full Text] [Related]
29. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.
Ito Y; Miyauchi A; Jikuzono T; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Ichihara K; Kuma K
World J Surg; 2007 Apr; 31(4):838-48. PubMed ID: 17347900
[TBL] [Abstract][Full Text] [Related]
30. A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
Wang W; Bai N; Li X
Front Endocrinol (Lausanne); 2022; 13():939131. PubMed ID: 36339438
[TBL] [Abstract][Full Text] [Related]
31. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W
Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
[TBL] [Abstract][Full Text] [Related]
32. Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.
Wang LY; Palmer FL; Thomas D; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
Ann Surg Oncol; 2015 Feb; 22(2):441-5. PubMed ID: 25190124
[TBL] [Abstract][Full Text] [Related]
33. How Does The AJCC/TNM Staging System Eighth Edition Perform in Thyroid Cancer at A Major Middle Eastern Medical Center?
Alzahrani AS; Albalawi L; Mazi S; Mukhtar N; Aljamei H; Moria Y; Elsayed T; Amer L; Alanazi F; Alnasser L; Alqarni B; Fadel R; AlMatar A; Alqahtani A; Tuttle RM
Endocr Pract; 2021 Jun; 27(6):607-613. PubMed ID: 34120701
[TBL] [Abstract][Full Text] [Related]
34. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
35. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
36. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
38. The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2018 Jun; 88(6):950-956. PubMed ID: 29573277
[TBL] [Abstract][Full Text] [Related]
39. Subclassification of Tumor Extension and Nodal Metastasis in Papillary Thyroid Cancer to Improve Prognostic Accuracy of the Eighth Edition of the Tumor-Node-Metastasis Classification.
Ito Y; Miyauchi A; Kihara M; Masuoka H; Higashiyama T; Miya A
World J Surg; 2020 Feb; 44(2):336-345. PubMed ID: 31428837
[TBL] [Abstract][Full Text] [Related]
40. [Pathological staging criteria for carcinoma in the remnant stomach: an exploratory study].
Gao Z; Zhao X; Jiang K; Wang B; Li Y; Ye Y; Wang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):514-521. PubMed ID: 29774932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
